Cargando…
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
China faces the greatest challenge from stroke in the world. According to results from the Global Burden of Disease Study 2019, there were 3.94 million new stroke cases, 28.76 million prevalent cases and 2.19 million deaths due to stroke in China in 2019. Furthermore, stroke is also the leading caus...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614174/ https://www.ncbi.nlm.nih.gov/pubmed/35443985 http://dx.doi.org/10.1136/svn-2021-001374 |
_version_ | 1784820136717320192 |
---|---|
author | Wang, Yong-Jun Li, Zi-Xiao Gu, Hong-Qiu Zhai, Yi Zhou, Qi Jiang, Yong Zhao, Xing-Quan Wang, Yi-Long Yang, Xin Wang, Chun-Juan Meng, Xia Li, Hao Liu, Li-Ping Jing, Jing Wu, Jing Xu, An-Ding Dong, Qiang Wang, David Wang, Wen-Zhi Ma, Xu-Dong Zhao, Ji-Zong |
author_facet | Wang, Yong-Jun Li, Zi-Xiao Gu, Hong-Qiu Zhai, Yi Zhou, Qi Jiang, Yong Zhao, Xing-Quan Wang, Yi-Long Yang, Xin Wang, Chun-Juan Meng, Xia Li, Hao Liu, Li-Ping Jing, Jing Wu, Jing Xu, An-Ding Dong, Qiang Wang, David Wang, Wen-Zhi Ma, Xu-Dong Zhao, Ji-Zong |
author_sort | Wang, Yong-Jun |
collection | PubMed |
description | China faces the greatest challenge from stroke in the world. According to results from the Global Burden of Disease Study 2019, there were 3.94 million new stroke cases, 28.76 million prevalent cases and 2.19 million deaths due to stroke in China in 2019. Furthermore, stroke is also the leading cause of disability-adjusted life-year (DALY) in China, the number of DALYs reached 45.9 million in 2019. Several recent large-scale epidemiological surveys have updated the data on pre-existing conditions contributed to stroke. The age-adjusted prevalence of overweight among Chinese adults aged 18–69 years was 34.4%, and the prevalence of obesity was 16.8% in 2018. 50.9% of Chinese adults ≥18 years of age without history of hypertension had prehypertension in 2018. The weighted prevalence of hypertension in adults was 27.5% in 2018. The weighted prevalence of total diabetes and pre-diabetes diagnosed by the American Diabetes Association criteria were 12.8% and 35.2%, respectively, among Chinese adults ≥18 years of age in 2017. The weighted atrial fibrillation prevalence was 1.8% among Chinese adults ≥45 years of age and equates to being present in an estimated 7.9 million people in China. Data from 1672 tertiary public hospitals in the Hospital Quality Monitoring System (HQMS) showed that 3 411 168 stroke cases were admitted during 2019. Of those, 2 818 875 (82.6%) were ischaemic strokes (ISs), 485 474 (14.2%) were intracerebral haemorrhages (ICHs), 106 819 (3.1%) were subarachnoid haemorrhages (SAHs). The average age was 66 years old, and 59.6% were male. A total of 1379 (<0.1%), 2604 (0.5%), 1250 (1.2%) paediatric strokes (age <18 years) were identified among IS, ICH and SAH, respectively. Over one-third (1 231 519 (36.1%)) of the stroke cases were covered by urban resident basic medical insurance, followed by urban employee basic medical insurance (891 103 (26.1%)) and new rural cooperative medical schema (543 108 (15.9%)). The leading risk factor was hypertension (57.3% for IS, 69.9% for ICH and 44.1% for SAH), and the leading comorbidity was pneumonia or pulmonary infection (10.4% for IS, 34.6% for ICH and 29.7% for SAH). In-hospital death/discharge against medical advice rate was 8.5%, ranging from 6.0% for IS to 20.6% for SAH. The median and IQR of length of stay was 9.0 (6.0–13.0) days, ranging from 10.0 (7.0–13.0) in IS to 14.0 (8.0–22.0) in ICH. Similar data from 2847 secondary public hospitals or private hospitals in the HQMS were also reported. Data from HQMS showed that higher proportions of interprovincial admission to other provinces were seen in Inner Mongolia, Anhui, Tibet and Beijing. Higher proportions of interprovincial admission from other provinces were seen in Beijng, Tianjin, Shanghai and Ningxia. Data from 323 601 strokes from 1337 hospitals in the Chinese Stroke Center Alliance during 2019 demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS, ICH and SAH were 0.78±0.20, 0.69±0.27 and 0.60±0.31, respectively. |
format | Online Article Text |
id | pubmed-9614174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96141742022-10-29 China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Wang, Yong-Jun Li, Zi-Xiao Gu, Hong-Qiu Zhai, Yi Zhou, Qi Jiang, Yong Zhao, Xing-Quan Wang, Yi-Long Yang, Xin Wang, Chun-Juan Meng, Xia Li, Hao Liu, Li-Ping Jing, Jing Wu, Jing Xu, An-Ding Dong, Qiang Wang, David Wang, Wen-Zhi Ma, Xu-Dong Zhao, Ji-Zong Stroke Vasc Neurol Epidemiological Study China faces the greatest challenge from stroke in the world. According to results from the Global Burden of Disease Study 2019, there were 3.94 million new stroke cases, 28.76 million prevalent cases and 2.19 million deaths due to stroke in China in 2019. Furthermore, stroke is also the leading cause of disability-adjusted life-year (DALY) in China, the number of DALYs reached 45.9 million in 2019. Several recent large-scale epidemiological surveys have updated the data on pre-existing conditions contributed to stroke. The age-adjusted prevalence of overweight among Chinese adults aged 18–69 years was 34.4%, and the prevalence of obesity was 16.8% in 2018. 50.9% of Chinese adults ≥18 years of age without history of hypertension had prehypertension in 2018. The weighted prevalence of hypertension in adults was 27.5% in 2018. The weighted prevalence of total diabetes and pre-diabetes diagnosed by the American Diabetes Association criteria were 12.8% and 35.2%, respectively, among Chinese adults ≥18 years of age in 2017. The weighted atrial fibrillation prevalence was 1.8% among Chinese adults ≥45 years of age and equates to being present in an estimated 7.9 million people in China. Data from 1672 tertiary public hospitals in the Hospital Quality Monitoring System (HQMS) showed that 3 411 168 stroke cases were admitted during 2019. Of those, 2 818 875 (82.6%) were ischaemic strokes (ISs), 485 474 (14.2%) were intracerebral haemorrhages (ICHs), 106 819 (3.1%) were subarachnoid haemorrhages (SAHs). The average age was 66 years old, and 59.6% were male. A total of 1379 (<0.1%), 2604 (0.5%), 1250 (1.2%) paediatric strokes (age <18 years) were identified among IS, ICH and SAH, respectively. Over one-third (1 231 519 (36.1%)) of the stroke cases were covered by urban resident basic medical insurance, followed by urban employee basic medical insurance (891 103 (26.1%)) and new rural cooperative medical schema (543 108 (15.9%)). The leading risk factor was hypertension (57.3% for IS, 69.9% for ICH and 44.1% for SAH), and the leading comorbidity was pneumonia or pulmonary infection (10.4% for IS, 34.6% for ICH and 29.7% for SAH). In-hospital death/discharge against medical advice rate was 8.5%, ranging from 6.0% for IS to 20.6% for SAH. The median and IQR of length of stay was 9.0 (6.0–13.0) days, ranging from 10.0 (7.0–13.0) in IS to 14.0 (8.0–22.0) in ICH. Similar data from 2847 secondary public hospitals or private hospitals in the HQMS were also reported. Data from HQMS showed that higher proportions of interprovincial admission to other provinces were seen in Inner Mongolia, Anhui, Tibet and Beijing. Higher proportions of interprovincial admission from other provinces were seen in Beijng, Tianjin, Shanghai and Ningxia. Data from 323 601 strokes from 1337 hospitals in the Chinese Stroke Center Alliance during 2019 demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS, ICH and SAH were 0.78±0.20, 0.69±0.27 and 0.60±0.31, respectively. BMJ Publishing Group 2022-04-20 /pmc/articles/PMC9614174/ /pubmed/35443985 http://dx.doi.org/10.1136/svn-2021-001374 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiological Study Wang, Yong-Jun Li, Zi-Xiao Gu, Hong-Qiu Zhai, Yi Zhou, Qi Jiang, Yong Zhao, Xing-Quan Wang, Yi-Long Yang, Xin Wang, Chun-Juan Meng, Xia Li, Hao Liu, Li-Ping Jing, Jing Wu, Jing Xu, An-Ding Dong, Qiang Wang, David Wang, Wen-Zhi Ma, Xu-Dong Zhao, Ji-Zong China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title_full | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title_fullStr | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title_full_unstemmed | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title_short | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations |
title_sort | china stroke statistics: an update on the 2019 report from the national center for healthcare quality management in neurological diseases, china national clinical research center for neurological diseases, the chinese stroke association, national center for chronic and non-communicable disease control and prevention, chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations |
topic | Epidemiological Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614174/ https://www.ncbi.nlm.nih.gov/pubmed/35443985 http://dx.doi.org/10.1136/svn-2021-001374 |
work_keys_str_mv | AT wangyongjun chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT lizixiao chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT guhongqiu chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT zhaiyi chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT zhouqi chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT jiangyong chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT zhaoxingquan chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT wangyilong chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT yangxin chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT wangchunjuan chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT mengxia chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT lihao chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT liuliping chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT jingjing chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT wujing chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT xuanding chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT dongqiang chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT wangdavid chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT wangwenzhi chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT maxudong chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont AT zhaojizong chinastrokestatisticsanupdateonthe2019reportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecont |